Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients
Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients
The relationship between cytomegalovirus infection and recurrence of hepatitis C in liver
 transplant recipients remains controversial. Although some studies (Teixeira et al., 2000;
 Singh et al., 2005)have not found an association between recurrence of hepatitis C and CMV
 infection, studies such as Rosen et al. show that 50% of patients with CMV infection suffered
 cirrhosis durig follow-up period, while between not-infected patients the rate was 11%. To
 clarify this question, a non-interventional study will be carried out in order to assess if
 CMV replication is a risk factor for graft dysfunction in liver transplant recipients.
Inclusion Criteria:

 -  Men or women who underwent liver transplantation after hepatopathy caused by HCV,
 confirmed by pre-transplantation detection of HCV RNA

 -  Age > 18 years old

 Exclusion Criteria:

 -  Patients co-infected with HBV or HIV

 -  Patients who show other causes of liver disease